FDA Approves Weight Loss Drug Wegovy for Teens The FDA recently approved Wegovy (semaglutide), a GLP-1 receptor agonist, as a weight loss treatment for teens ages 12 and up
There is only one experimental study of LC supplementation in patients with chronic fatigue syndrome, as shown in Table 12 below
However, these new therapies have drawbacks
This nausea tends to be mild to moderate in severity and often improves with continued use as tolerance develops
They don't contain actual GLP-1 medications and have no clinical evidence supporting their effectiveness
As weight-loss drugs reduce appetites, US restaurants cut portion sizes Some New York restaurants are offering smaller portions at lower prices to appeal to those on hunger-reducing GLP-1 weight-loss medications A foodie, social butterfly and New Yorker for 20 years, Lina Axmacher has loved exploring the citys famed restaurant culture for a long time